37 related articles for article (PubMed ID: 9572583)
1. Membrane trafficking regulates the activity of the human dopamine transporter.
Melikian HE; Buckley KM
J Neurosci; 1999 Sep; 19(18):7699-710. PubMed ID: 10479674
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter.
Cao BJ; Reith ME
Br J Pharmacol; 2002 Dec; 137(8):1155-62. PubMed ID: 12466224
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Isoquinoline Alkaloids Agonists of Acid-Sensing Ion Channel Type 3.
Osmakov DI; Koshelev SG; Andreev YA; Kozlov SA
Front Mol Neurosci; 2017; 10():282. PubMed ID: 28955199
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
Wąsik A; Romańska I; Antkiewicz-Michaluk L
Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
[TBL] [Abstract][Full Text] [Related]
5. (R,S)-tetrahydropapaveroline production by stepwise fermentation using engineered Escherichia coli.
Nakagawa A; Matsuzaki C; Matsumura E; Koyanagi T; Katayama T; Yamamoto K; Sato F; Kumagai H; Minami H
Sci Rep; 2014 Oct; 4():6695. PubMed ID: 25331563
[TBL] [Abstract][Full Text] [Related]
6. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat.
Wąsik A; Romańska I; Michaluk J; Kajta M; Antkiewicz-Michaluk L
Neurotox Res; 2014 Oct; 26(3):240-54. PubMed ID: 24842650
[TBL] [Abstract][Full Text] [Related]
7. Concentration-dependent opposite effects of 1-benzyl-1,2,3,4-tetrahydroisoquinoline on markers of apoptosis: in vitro and ex vivo studies.
Wąsik A; Kajta M; Lenda T; Antkiewicz-Michaluk L
Neurotox Res; 2014 Jan; 25(1):90-9. PubMed ID: 24190811
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease, L-DOPA, and endogenous morphine: a revisit.
Stefano GB; Mantione KJ; Králíčková M; Ptacek R; Kuzelova H; Esch T; Kream RM
Med Sci Monit; 2012 Aug; 18(8):RA133-137. PubMed ID: 22847214
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms.
Surh YJ; Kim HJ
Exp Neurobiol; 2010 Sep; 19(2):63-70. PubMed ID: 22110343
[TBL] [Abstract][Full Text] [Related]
10. Dopamine, morphine, and nitric oxide: an evolutionary signaling triad.
Stefano GB; Kream RM
CNS Neurosci Ther; 2010 Jun; 16(3):e124-37. PubMed ID: 19912274
[TBL] [Abstract][Full Text] [Related]
11. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies.
Wasik A; Romańska I; Antkiewicz-Michaluk L
Neurotox Res; 2009 Jan; 15(1):15-23. PubMed ID: 19384584
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
13. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
[TBL] [Abstract][Full Text] [Related]
14. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
15. Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance.
Hitri A; Hurd YL; Wyatt RJ; Deutsch SI
Clin Neuropharmacol; 1994 Feb; 17(1):1-22. PubMed ID: 8149355
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells.
Okada T; Shimada S; Sato K; Kotake Y; Kawai H; Ohta S; Tohyama M; Nishimura T
Neurosci Res; 1998 Jan; 30(1):87-90. PubMed ID: 9572583
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
